The effect of aminoguanidine against cholestatic liver injury in rats

Cell Biochemistry and Function

Volumn 25, Issue 6, 2007, Pages 625-632

  Yilmaz, Mehmet ^a   Ara, Cengiz ^a,b   Isik, Burak ^a   Karadag, Nȩe ^a   Yilmaz, Sezai ^a   Polat, Alattin ^a   Coban, Sacit ^a   Duzova, Halil ^a  

^a INONU UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Aminoguanidine; Bile duct ligation; Cytokine; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOGUANIDINE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYTOKINE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; GUANIDINE DERIVATIVE; MALONALDEHYDE; PEROXIDASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BILE DUCT OBSTRUCTION; BILIARY CIRRHOSIS; CELL PROLIFERATION; CHOLESTASIS; COMMON BILE DUCT; CONTROLLED STUDY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS; LAPAROTOMY; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; STATISTICAL SIGNIFICANCE; ANIMAL; DRUG EFFECT; EXPERIMENTAL LIVER CIRRHOSIS; INJURY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; LIVER DISEASE; METABOLISM;

RATTUS;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CHOLESTASIS; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; GUANIDINES; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1ALPHA; INTERLEUKIN-6; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER DISEASES; MALE; MALONDIALDEHYDE; PEROXIDASE; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38449094385     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1359     Document Type: Article

References (33)

1. Okazaki T, Kobayashi H, Yamataka A, Lane GJ, Miyano T. Long-term postsurgical outcome of biliary atresia. J Pediatr Surg 1999; 34: 312-315.
2. Roggin KK, Kim JC, Kurkchubasche AG, Papa EF, Vezeridis AM, Tracy TF. Macrophage phenotype during cholestatic injury and repair: the persistent inflammatory response. J Pediatr Surg 2001; 36: 220-228.
3. Karaman A, Demirbilek S, Sezgin N, Gurbuz N, Gurses I. Protective effect of polyunsaturated phosphatidylcholine on liver damage induced by biliary obstruction in rats. J Pediatr Surg 2003; 38: 1341-1347.
4. Sokol RJ, Devereaux M, Khandwala RA. Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. Lipid Res 1991; 32: 1349-1357.
5. Ara C, Kirimlioglu H, Karabulut AB, et al. Protective effect of resveratrol against oxidative stress in cholestasis. J Surg Res 2005; 127: 112-117.
6. Gonzalez-Correa JA, De La Cruz JP, Martin-Aurioles E, Lopez-Egea MA, Ortiz P, Sanchez de la Cuesta F. Effects of S-adenosyl-L-methionine on hepatic and renal oxidative stress in an experimental model of acute biliary obstruction in rats. Hepatology 1997; 26: 121-127.
7. Seto Y, Nakashima T, Shima T, Sakamoto Y, Okonu T, Takino T. Involvement of oxygen radicals in bile acid-induced hepatocytes injury. Hepatology 1998; 8: 1452.
8. Misko TP, Moore WM, Kasten TP, et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993; 233: 119-125.
9. Ihm SH, Yoo HJ, Park SW, Ihm J. Effect of aminoguanidine on lipid peroxidation in streptozotocin-induced diabetic rats. Metabolism 1999; 48: 1141-1145.
10. Szabo C, Ferrer-Sueta G, Zingarelli B, Southan GJ, Salzman AL, Radi R. Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 1997; 272: 9030-9036.
11. Shiomi M, Wakabayashi Y, Sano T, et al. Nitric oxide suppression reversibly attenuates mitochondrial dysfunction and cholestasis in endotoxemic rat liver. Hepatology 1998; 27: 108-115.
12. Pastor A, Collado PS, Almar M, Gonzalez-Gallego J. Microsomal function in biliary obstructed rats: effects of S-adenosylmethionine. J Hepatol 1996; 24: 353-359.
13. Takizawa S, Fukuyama N, Hirabayashi H, Nakazawa H, Shinohara Y. Dynamics of nitrotyrosine formation and decay in rat brain during focal ischemia-reperfusion. J Cereb Blood Flow Metab 1999; 19: 667-672.
14. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86: 271-278.
15. Wei H, Frenkel K. In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin. Cancer Res 1991; 51: 4443-4449.
16. Gurlek A, Aydogan H, Parlakpinar H, et al. Protective effect of melatonin on random pattern skin flap necrosis in pinealectomized rat. J Pineal Res 2004; 36: 58-63.
17. Krahenbuhl S, Talos C, Lauterburg BH, Reichen J. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology 1995; 22: 607-612.
18. Canturk NZ, Canturk Z, Utkan NZ, et al. Cytoprotective effects of alpha tocopherol against liver injury induced by extrahepatic biliary obstruction. East Afr Med J 1998; 75: 77-80.
19. Ohta Y, Kongo M, Kishikawa T Melatonin exerts a therapeutic effect on cholestatic liver injury in rats with bile duct ligation. J Pineal Res 2003; 34: 119-126.
20. Ohta Y, Kongo M, Kishikawa T. Therapeutic effect of melatonin on cholestatic liver injury in rats with bile duct ligation. Adv Exp Med Biol 2003; 527: 559-565.
21. Gurel A, Armutcu F, Sahin S, et al. Protective role of alpha-tocopherol and caffeic acid phenethyl ester on ischemia-reperfusion injury via nitric oxide and myeloperoxidase in rat kidneys. Clin Chim Acta 2004; 339: 33-41.
22. Orellana M, Rodrigo R, Thielemann L, Guajardo V. Bile duct ligation and oxidative stress in the rat: effects in liver and kidney. Comp Biochem Physiol Toxicol Pharmacol 2000; 126: 105-111.
23. Padillo FJ, Cruz A, Navarrete C, et al. Melatonin prevents oxidative stress and hepatocyte cell death induced by experimental cholestasis. Free Radic Res 2004; 38: 697-704.
24. Bulbuller N, Akkus MA, Cetinkaya Z, et al. Effects of melatonin and lactulose on the liver and kidneys in rats with obstructive jaundice. Pediatr Surg Int 2002; 18: 677-680.
25. Giardino I, Fard AK, Hatchell DL, Brownlee M. Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 1998; 47: 1114-1120.
26. Parlakpinar H, Koc M, Polat A, et al. Protective effect of aminoguanidine against nephrotoxicity induced by amikacin in rats. Urol Res 2004; 32: 278-282.
27. Reilly PM, Schiller HJ, Bulkley GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen β metabolites. Am J Surg 1991; 161: 488.
28. Muriel P, Suarez R. Role of lipid peroxidation in biliary obstruction in the rat. J Appl Toxicol 1994; 14: 423.
29. Lee FY, Lu RH, Tsai YT, et al. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation. Scandinavian J Gastroenterol 1996; 31: 500-505.
30. Bemelmans MH, Gouma DJ, Greve JW, Buurman WA. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 1992: 15: 1132.
31. Sewnath ME, Van Der Poll T, Ten Kate FJ, Van Noorden CJ, Gouma DJ. Interleukin-1 receptor type 1 gene-deficient bile duct-ligated mice are partially protected against endotoxin. Hepatology 2002; 35: 149-158.
32. Xiao W, Hodge DR, Wang L, Yang X, Zhang X, Farrar WL. Co-operative functions between nuclear factors NFkappaB and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells. Prostate 2004; 61: 354-370.
33. Natarajan K, Singh S, Burke TR, Grunberger D, Jr., Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc Natl Acad Sci 1996; 93: 9090-9095.